| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/28/2009 | EP2018367A1 Novel microbiocides |
| 01/28/2009 | EP1670761B1 Tetrahydro-naphthalene and urea derivatives |
| 01/28/2009 | EP1446400B1 Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 01/28/2009 | EP1177181B1 Substituted bicyclic compounds |
| 01/28/2009 | EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 01/28/2009 | CN101356171A N4-phenyl-quinaz0line-4-amine derivatives and related compounds as ERBBI type receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 01/28/2009 | CN101356161A Heterocyclic CETP inhibitors |
| 01/28/2009 | CN101356160A Trisubstituted quinazolinone derivatives as vanilloid antagonists |
| 01/28/2009 | CN101356159A Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2H)-isoquinolones and methods of use thereof |
| 01/28/2009 | CN101356156A Aspartic protease inhibitors |
| 01/28/2009 | CN101353348A 7-[4-(aminomethyl)-4-fluoro-3-(alkoxyimine) pyrrolidine-1-yl] substituted quinoline carboxylic acid derivative and preparation thereof |
| 01/28/2009 | CN101353344A Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 01/28/2009 | CN101353343A Preparation of high-purity nolatrexed dihydrochloride dihydrate |
| 01/28/2009 | CN101353342A 2-pyridinyl-1H-benzimidazole-4-acidamide type derivative |
| 01/28/2009 | CN101353320A Matrix metalloprotease inhibitors, medicinal composition containing the same, preparation and use thereof |
| 01/28/2009 | CN100455579C Compounds and compositions as protein kinase inhibitors |
| 01/28/2009 | CN100455570C Quinolinone / benzoxazinone derivatives and uses thereof |
| 01/28/2009 | CN100455568C 6-position substituted indoline, production and use thereof as medicament |
| 01/27/2009 | US7482472 Such as 2-(4-[[(5-chloro-2-thienyl)carbonyl]amino]-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid; blood coagulation; treating thromboembolic disorders (myocardial infarction, angina pectoris, reocclusions and restenoses after angioplasty/aortocoronary bypass, stroke), atherosclerosis and arthritis |
| 01/27/2009 | US7482463 Amorphous form of esomeprazole salts |
| 01/27/2009 | US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 01/27/2009 | US7482458 Quinoline derivatives |
| 01/27/2009 | US7482456 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors |
| 01/27/2009 | US7482455 Chemical compounds |
| 01/27/2009 | US7482454 Antimicrobial quinolones, their compositions, and uses |
| 01/27/2009 | US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/27/2009 | US7482373 useful in the treatment of central or peripheral nervous system disorders; psychological disorders; gastrointestinal disorders |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482368 Triamide-substituted heterobicyclic compounds |
| 01/27/2009 | US7482367 Substituted benzimidazoles and methods of their use |
| 01/27/2009 | US7482366 Modulators of LXR |
| 01/27/2009 | US7482365 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases |
| 01/27/2009 | US7482364 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine |
| 01/27/2009 | US7482358 2-(5-cyano-3-pyridyl)-4-(4-fluorophenyl)-4-(6-fluoro-3-pyridyl)-5-methyl-2-imidazoline; obesity, bulimia; antidiabetic agents; neuropeptide Y receptor antagonists |
| 01/27/2009 | US7482355 Pyrimidine derivatives as modulators of chemokine receptor activity |
| 01/27/2009 | US7482352 Such as N6-[6-(2-dimethylaminoethylamino)-4-methylsulfanyl-[1,3,5]triazin-2-yl]-2-methylquinoline-4,6-diamine, which stabilizes DNA in G-quadruplex structures (guanine tetrads); anticancer agents |
| 01/27/2009 | US7482351 Against breast, colon, pancreatic, lung, bone, or renal tumor cells; antimetastasis agents; administered orally or intravenously; combined with chemotherapy to reduce generation of drug resistance |
| 01/27/2009 | US7482350 4,5-disubstituted-2-aryl pyrimidines |
| 01/27/2009 | US7482349 And beta-amyloid formation; Alzheimer's Disease; 2-amino-5-(4-fluoro-3-pyrimidin-5-ylphenyl)-5-(4-methoxy-3-methylphenyl)-3-methyl-3,5- dihydro-4H-imidazol-4-one |
| 01/27/2009 | US7482347 CCR-3 receptor antagonists; inflammatory or allergic condition such as asthma or obstructive airway disease; 1-[1-(3,5-Dimethylisoxazole-4-sulfonyl)-piperdin-4-yl-methyl]-4-(4-fluorobenzyl)-piperazine; 1-(4-Fluorobenzyl)-4-(4-piperidinylmethyl) piperazine intermediate and a sulfonyl halide reactant |
| 01/27/2009 | US7482346 Carboxylation of the alkylpiperazine; amidation of the carbamate-ester; cannabinoid and vanilloid receptor antagonists |
| 01/27/2009 | US7482345 P38 kinase inhibiting agents |
| 01/27/2009 | US7482344 5-substituted arylmethylidenyl (thio)xanthenes; hypotensive agents, antiinflammatory agents, antiarthritic agents; congestive heart failure |
| 01/27/2009 | US7482342 Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors |
| 01/27/2009 | US7482341 N-(pyridin-2-yl)-benzenesulfonamides; antidiabetic agents for Type II Diabetes; obesity; 11beta-hydroxysteroid dehydrogenase inhibitors |
| 01/27/2009 | US7482335 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 01/27/2009 | CA2389280C Triazoles as farnesyl transferase inhibitors |
| 01/27/2009 | CA2388646C Methods and compositions utilizing quinazolinones |
| 01/27/2009 | CA2377226C Benzimidazole compounds and medicaments comprising the same |
| 01/27/2009 | CA2290520C Inhibition of p38 kinase activity by aryl ureas |
| 01/27/2009 | CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 01/27/2009 | CA2206238C Alkylidenehydrazinophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators |
| 01/22/2009 | WO2009012421A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
| 01/22/2009 | WO2009012283A1 Compounds and methods for kinase modulation, and indications therefor |
| 01/22/2009 | WO2009012277A1 Method for modulating gpr119 g protein-coupled receptor and selected compounds |
| 01/22/2009 | WO2009012275A1 Pyridone gpr119 g protein-coupled receptor agonists |
| 01/22/2009 | WO2009012259A1 Pentafluorosulfanyl-substituted piperazinylpiperidine derivatives as chemokine receptor antagonists |
| 01/22/2009 | WO2009011880A2 Heterocyclic modulators of pkb |
| 01/22/2009 | WO2009011627A1 Pyridine compounds and their use as p2y12 antagonists |
| 01/22/2009 | WO2009011336A1 Quinoline compounds |
| 01/22/2009 | WO2009011285A1 Heteroarylbenzene compounds |
| 01/22/2009 | WO2009011131A1 Optical recording medium and azo copper chelate compound |
| 01/22/2009 | WO2009010937A1 Process for the preparation op pantoprazole sodium and pantoprazole sodium sesquihydrate |
| 01/22/2009 | WO2009010794A1 2,4-diamino-pyrimidine derivatives |
| 01/22/2009 | WO2009010660A2 Substituted indazoles, the preparation thereof, and use of same in therapeutics |
| 01/22/2009 | WO2009010560A1 Pyrazole derivatives and use thereof as inhibitors of stearoyl-coa desaturase |
| 01/22/2009 | WO2009010479A2 Heterocyclic methylene piperidine derivatives and their use |
| 01/22/2009 | WO2009010478A2 Use of piperidine derivatives as agonists of chemokine receptor activity |
| 01/22/2009 | WO2009010429A2 Novel heterocyclyl compounds and their use as chemokine antagonists |
| 01/22/2009 | WO2009010299A1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 01/22/2009 | WO2009010260A2 Condensed anthranilamide insecticides |
| 01/22/2009 | WO2009010129A1 Bispidon ligands and the metal complexes thereof |
| 01/22/2009 | WO2008138754A3 New solid forms of fxa inhibitors |
| 01/22/2009 | WO2008130021A3 Heterocyclic hydrazide compound and pesticidal use of the same |
| 01/22/2009 | WO2008101935A3 New indole derivative compounds and pharmaceutical compositions containing the same |
| 01/22/2009 | WO2008083367A4 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/22/2009 | US20090023922 Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof |
| 01/22/2009 | US20090023917 Selective Estrogen Receptor Modulators for the Treatment of Vasomotor Symptoms |
| 01/22/2009 | US20090023916 Tetrazine-based bio-orthogonal coupling reagents and methods |
| 01/22/2009 | US20090023788 Treatment of CRTH2-mediated diseases and conditions |
| 01/22/2009 | US20090023785 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/22/2009 | US20090023777 Substituted 4-amino-benzylpiperidine compounds |
| 01/22/2009 | US20090023776 Farnesyl protein transferase inhibitor combinations with antiestrogen agents |
| 01/22/2009 | US20090023775 1-[2-(4-benzyl-4-hydroxy-piperidin-1 -yl )-ethyl]-3-(2-methyl-quinolin- 4-yl)- urea as crystalline sulfate salt |
| 01/22/2009 | US20090023773 Compositions and methods for modulating gated ion channels |
| 01/22/2009 | US20090023763 Condensed Pyridine Derivatives Useful as A2B Adenosine Receptor Antagonists |
| 01/22/2009 | US20090023761 Heterocyclic compounds and their uses |
| 01/22/2009 | US20090023759 Quinazoline Derivatives as Inhibitors of EGF and/or erbB2 Receptor Tyrosine Kinase |
| 01/22/2009 | US20090023758 Macrocyclic Inhibitors of Hepatitis C Virus |
| 01/22/2009 | US20090023752 N-Heterocyclylphthaldiamides as Insecticides |
| 01/22/2009 | US20090023746 Compounds and their uses 707 |
| 01/22/2009 | US20090023738 Diaminopyrimidines as modulators of the ep2 receptor |
| 01/22/2009 | US20090023734 Treating cell proliferative disorders |
| 01/22/2009 | US20090023733 Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them |
| 01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
| 01/22/2009 | US20090023729 Trisubstituted amine compound |
| 01/22/2009 | US20090023728 1,2,3,4-Tetrahydroisoquinoline Derivatives, Preparations Thereof and Uses Thereof |
| 01/22/2009 | US20090023726 ovarian cancer; HDAC inhibitors for example N-hydroxy-2-(4-(heteroarylmethylaminomethyl)piperidino)-pyrimidine-5-amide |
| 01/22/2009 | US20090023725 Fused Heteroaryl Derivatives for Use as P38 Kinase Inhibitors |
| 01/22/2009 | US20090023718 Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives |